What the Gold/Apel team have achieved is certainly a remarkable and major achievment in the annals of mmj. This is big. Dharmanol is unique. SK has exclusive rights. Not to forget  Berkeley Bio is a sub of SK.

The cancer studies have been using synthetic THC to avoid legal problems, but Gold/Apel group have opened up a broad new vista by introducing to everyone the full range of benefits from the natural cannabanoid complex. Now, patients have access to the healing benefit of Dharmanol which contains the cannabanoid complex (CBD, THC etc.) without psycho-active side effects. Those side effects had limited treatment options for certain patients.

Plus, Dharmanol contains terpenes, naturally occurring substances in cannabis. Terpenes have been shown to have powerful antibacterial, antiviral, antifungal and antiparasitic properties.

The human body has a built-in endo-cannabinoid system that plays a role in immune response, anti-inflammation and a number of other important disease fighting functions. Dharmanol works with body not against it in fighting and resisting diseases.